Due to the crucial roles of IL-17 and TNF-α in autoimmune diseases and the contribution of NDR1 in IL-17 signaling, NDR1 could be a potential target for drug discovery of autoimmune diseases like EAE, RA, IBD, MS, and UC. The gene discussed is STK38; the disease is myeloid sarcoma.